In Vitro Activity of HSR-903, a New Oral Quinolone, against Bacteria Causing Respiratory Infections

The in vitro activity of HSR-903, an oral quinolone, against 196 recent clinical isolates of respiratory pathogens was evaluated. HSR-903 was 2 to 32 times more active than ofloxacin, ciprofloxacin, and sparfloxacin against Staphylococcus aureus, including methicillin-resistant strains, and Streptoc...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Watanabe, Akira, Tokue, Yutaka, Takahashi, Hiroshi, Kikuchi, Tohru, Kobayashi, Takao, Gomi, Kazunori, Fujimura, Shigeru, Nukiwa, Toshihiro
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 1999
Konular:
Susceptibility
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC89361/
https://ncbi.nlm.nih.gov/pubmed/10390240
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller